Trastuzumab deruxtecan
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Trastuzumab deruxtecan
May 11, 2024, 11:39 |
Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 9, 2024, 00:21 |
Blog
Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors
Enes Erul, Oncology Fellow at Ankara Üniversitesi, shared on X: “Trastuzumab deruxtecan shows promise in HER2-mutant…
May 4, 2024, 10:27 |
Insight
Paolo Tarantino: HER2 is about to change again
Paolo Tarantino shared a previous post of him on X and added: "HER2 is about…
Apr 29, 2024, 15:54 |
Insight
Toni Choueiri: Big news to start the day: DESTINY-Breast06 Phase III trial
Toni Choueiri shared on X: "Big news to start the day: DESTINY-Breast06 Phase III trial…
Apr 22, 2024, 19:23 |
Insight
New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation
A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…
Apr 11, 2024, 14:45 |
Insight
Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 8, 2024, 16:01 |
Drugs
Rahul Gosain: Trastuzumab Deruxtecan now is FDA approved, Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 6, 2024, 10:04 |
Drugs
Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open
Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post…
Jan 29, 2024, 13:37 |
Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Jan 7, 2024, 15:14 |
Drugs
Paolo Tarantino: Decades of cancer research converging on new effective treatment options for our patients with HR-positive breast cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared on LinkedIn:…
All:
10
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube